Urologists say don’t give up on prostate cancer screening just yet

NewsGuard 100/100 Score

What's a guy to do? While prostate specific antigen (PSA) testing has been the standard screening tool for prostate cancer for several decades, results of a study recently published in The New England Journal of Medicine question the effectiveness of PSA screening in reducing death from prostate cancer. But many urologists argue that men should not be swayed from getting the test-it still saves lives.

Matthew Shuford, M.D., urologist on the medical staff at Baylor University Medical Center at Dallas, sees no reason to give up the PSA screening in light of the recent findings.

"Prostate cancer is the most common cancer in men and the second leading cause of cancer death in men," says Dr. Shuford. "Keep in mind that it is only curable when caught early; it can only be caught early by screening; and the screening is a simple blood test that is cheap and easy."

Approximately 90 percent of all prostate cancers are currently diagnosed at an early stage, according to the National Cancer Institute.

"Early diagnosis greatly increases a man's chances of successful treatment," adds Dr. Shuford.

Prostate cancer screening includes a digital rectal exam (DRE) and a simple PSA blood test. The American Cancer Society recommends men talk with their physician about a regular screening plan.

While some men might complain that the DRE screening is too uncomfortable and some researchers might suggest that the PSA test is not necessary, Dr. Shuford is quick to compare the screening to other cancer screening tests.

"Colon cancer screening, for example, is a more expensive and a more invasive procedure than prostate cancer screening, involving the increased complications of anesthesia with the added discomfort of a bowel prep," he said. "This is accepted despite the fact that the vast majority of people will have no abnormality found and even fewer will have colon cancer."

"What if a blood test existed for colon cancer," asks Dr. Shuford. "I can't think of anyone who would say no to a blood test that may let them avoid a colonoscopy," he said. "This is what the PSA test does for prostate cancer."

Comments

  1. CB CB United States says:

    Of 100,000 deaths over age 65 only 226 are related to prostate cancer - although 60% over age 65 have prostate cancer.  The vast majority die with it - not of it.  Unproven tests and operations have become a multi billion dollar industry - some are calling it a barbaric industry.  

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Liver cells effectively serve as immune checkpoint regulating anti-cancer immunity